Drug Shortage Report for OMNIPAQUE 180

Last updated on 2021-07-10 History
Report ID 141914
Drug Identification Number 02172720
Brand name OMNIPAQUE 180
Common or Proper name Omnipaque 180mg 20ml
Company Name GE HEALTHCARE CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) IOHEXOL
Strength(s) 388MG
Dosage form(s) SOLUTION
Route of administration SUBARACHNOIDAL SUBARACHNOIDAL
Packaging size Box of 10 vials
ATC code V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-07-06
Actual start date 2021-07-06
Estimated end date 2021-07-08
Actual end date 2021-07-09
Shortage status Resolved
Updated date 2021-07-10
Company comments QA released.
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@ge.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-07-10 English Compare
v5 2021-07-09 French Compare
v4 2021-07-09 English Compare
v3 2021-07-07 English Compare
v2 2021-07-06 French Compare
v1 2021-07-06 English Compare

Showing 1 to 6 of 6